257 related articles for article (PubMed ID: 20634176)
21. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of colesevelam on lowering glycemia and lipids.
Aggarwal S; Loomba RS; Arora RR
J Cardiovasc Pharmacol; 2012 Feb; 59(2):198-205. PubMed ID: 21983746
[TBL] [Abstract][Full Text] [Related]
23. Diurnal glucose profiles using continuous glucose monitoring to identify the glucose-lowering characteristics of colesevelam HCl (Welchol).
Mazze RS; Strock ES; Monk AM; Murphy MM; Xi M; Bergenstal RM
Endocr Pract; 2013; 19(2):275-83. PubMed ID: 23598534
[TBL] [Abstract][Full Text] [Related]
24. Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
Florentin M; Liberopoulos EN; Rizos CV; Kei AA; Liamis G; Kostapanos MS; Elisaf MS
Metab Syndr Relat Disord; 2013 Jun; 11(3):152-6. PubMed ID: 23170931
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
Knopp RH; Tsunehara C; Retzlaff BM; Fish B; Nguyen H; Anderson S; Nguyen T
Metabolism; 2006 Dec; 55(12):1697-703. PubMed ID: 17142146
[TBL] [Abstract][Full Text] [Related]
26. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
Dayer-Berenson L; Finckenor M
Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
[TBL] [Abstract][Full Text] [Related]
27. Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose.
Davidson MH; Rooney M; Pollock E; Drucker J; Choy Y
J Clin Lipidol; 2013; 7(5):423-32. PubMed ID: 24079283
[TBL] [Abstract][Full Text] [Related]
28. Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.
Davidson MH; Toth P; Weiss S; McKenney J; Hunninghake D; Isaacsohn J; Donovan JM; Burke SK
Clin Cardiol; 2001 Jun; 24(6):467-74. PubMed ID: 11403509
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Gavin JR; Jones MR; Ford DM; Truitt KE
Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
[TBL] [Abstract][Full Text] [Related]
30. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
Perry CM
Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
[TBL] [Abstract][Full Text] [Related]
31. Colesevelam: a new and improved bile acid sequestrant?
Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
[TBL] [Abstract][Full Text] [Related]
32. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
Bays H; Rhyne J; Abby S; Lai YL; Jones M
Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
[TBL] [Abstract][Full Text] [Related]
33. Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.
Rosenstock J; Hernandez-Triana E; Handelsman Y; Misir S; Jones MR; Nagendran S
Postgrad Med; 2012 Jul; 124(4):7-13. PubMed ID: 22913889
[TBL] [Abstract][Full Text] [Related]
34. Colesevelam hydrochloride: a novel bile acid-binding resin.
Aldridge MA; Ito MK
Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
[TBL] [Abstract][Full Text] [Related]
35. Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia.
Rosenson RS
Atherosclerosis; 2006 Apr; 185(2):327-30. PubMed ID: 16009365
[TBL] [Abstract][Full Text] [Related]
36. Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
Diab Vasc Dis Res; 2013 May; 10(3):256-62. PubMed ID: 23152373
[TBL] [Abstract][Full Text] [Related]
37. Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively.
Hunninghake D; Insull W; Toth P; Davidson D; Donovan JM; Burke SK
Atherosclerosis; 2001 Oct; 158(2):407-16. PubMed ID: 11583720
[TBL] [Abstract][Full Text] [Related]
38. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
[TBL] [Abstract][Full Text] [Related]
39. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.
Rosenstock J; Rigby SP; Ford DM; Tao B; Chou HS
Horm Metab Res; 2014 May; 46(5):348-53. PubMed ID: 24356792
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
Younk LM; Davis SN
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
